Cardiac function in congenital adrenal hyperplasia: a pattern of reversible cardiomyopathy

Mary S Minette1, Andrew W Hoyer, Phat P Pham

  • 1Division of Pediatric Cardiology, Department of Pediatrics, Oregon Health & Science University, Portland, OR 97239, USA. minettem@ohsu.edu

The Journal of Pediatrics
|January 23, 2013
PubMed

Insights

Newborns with congenital adrenal hyperplasia (CAH) show cardiac dysfunction that improves with corticosteroid therapy. This suggests corticosteroids directly impact newborn heart function.

Area of Science:

  • Pediatric Endocrinology
  • Neonatal Cardiology
  • Pediatric Cardiology

Background:

  • Congenital adrenal hyperplasia (CAH) can affect multiple organ systems.
  • Cardiac function in infants with CAH requires further investigation.
  • The impact of corticosteroid replacement on neonatal cardiac health is not fully understood.

Purpose of the Study:

  • To assess cardiac function in infants diagnosed with congenital adrenal hyperplasia (CAH).
  • To evaluate the effects of corticosteroid replacement therapy on cardiac parameters in infants with CAH.
  • To compare cardiac function in infants with CAH to a healthy control group.

Main Methods:

  • Prospective case-control study involving 9 infants with CAH and 6 healthy term infants.
  • Echocardiography was performed at presentation and after corticosteroid replacement therapy in infants with CAH.
  • Cardiac function was assessed using fractional shortening (FS), velocity of circumferential fiber shortening (Vcf), wall stress, and other echocardiographic indices.

Main Results:

  • Infants with CAH presented with myocardial dysfunction and lower systolic blood pressure (SBP) compared to controls.
  • Fractional shortening (FS) and Vcf significantly improved after corticosteroid treatment in infants with CAH.
  • Systolic blood pressure (SBP) also increased significantly following corticosteroid therapy in the CAH group.

Conclusions:

  • Newborns with CAH exhibit cardiac dysfunction at baseline.
  • Corticosteroid replacement therapy effectively reverses cardiac dysfunction in infants with CAH.
  • These findings indicate a direct role for corticosteroids in modulating cardiac function in newborns.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...